Review of Palliative Radiotherapy in the Management of Advanced Head and Neck Cancer

This study has been completed.

Sponsored by:	Alberta Cancer Board
Information provided by:	Alberta Cancer Board
ClinicalTrials.gov Identifier:	NCT00280891

Purpose

To describe the charactersitics of patients with advanced head and neck cancer treated with palliative intent and determine outcome in terms of symptom control and toxicity

Condition
Head and Neck Cancer

MedlinePlus related topics: Cancer Head and Neck Cancer

U.S. FDA Resources

Study Type:	Observational
Study Design:	Retrospective
Official Title:	Review of Palliative Radiotherapy in the Management of Advanced Head and Neck Cancer

Further study details as provided by Alberta Cancer Board:

Estimated Enrollment:	100
Study Start Date:	January 2006
Study Completion Date:	June 2006

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

squamous cell carcinoma of the head and neck, primary treatment given with palliative intent

Exclusion Criteria:

radical treatment, palliative treatment following local recurrence, adenocarcinoma, salivary gland carcinoma or melanoma

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00280891

Locations

Canada, Alberta
Tom Baker Cancer Centre
Calgary, Alberta, Canada, T2N 4N2

Sponsors and Collaborators

Alberta Cancer Board

Investigators

Principal Investigator:

Harold Lau, MD

Alberta Cancerboard

More Information

Study ID Numbers:	18882
Study First Received:	January 20, 2006
Last Updated:	August 15, 2008
ClinicalTrials.gov Identifier:	NCT00280891
Health Authority:	Canada: Health Canada

Keywords provided by Alberta Cancer Board:

head and neck
cancer
palliation
radiotherapy

Study placed in the following topic categories:

Head and Neck Neoplasms

Additional relevant MeSH terms:

Neoplasms
Neoplasms by Site

ClinicalTrials.gov processed this record on January 15, 2009